UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service

Strauss, Sandra; (2023) Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service. International Journal of Cancer , 152 (9) pp. 1789-1803. 10.1002/ijc.34409. Green open access

[thumbnail of Strauss_Intl Journal of Cancer - 2022 - Bacon - Incidence and survival of soft tissue sarcoma in England between 2013 and 2017  an.pdf]
Preview
Text
Strauss_Intl Journal of Cancer - 2022 - Bacon - Incidence and survival of soft tissue sarcoma in England between 2013 and 2017 an.pdf

Download (1MB) | Preview

Abstract

There is a paucity of population-based data detailing the incidence and survival of patients with soft tissue sarcoma (STS), in part due to the heterogeneity of disease and changes to classification. Here, the incidence and survival of all STS subtypes registered in England between 2013 and 2017 were analysed using cancer registry data held by the National Cancer Registration and Analysis Service. Age-standardised incidence rates were calculated per 1 000 000 using the 2013 European Standard Population. Net survival was computed using Brenner's alternative method, with the Ederer II estimator. Age-specific overall survival was assessed using Kaplan-Meier. The influence of age, sex, socioeconomic deprivation and diagnostic routes on survival was assessed using Cox proportional hazards modelling. In total, 19 717 patients were diagnosed with STS, an average of 3943 patients per year and representing approximately 0.8% of malignancies. The most common histological diagnoses were Gastrointestinal Stromal Tumours (GIST), leiomyosarcoma and undifferentiated sarcoma, accounting for 20.2%, 13.3% and 12.7% of all sarcomas, respectively. Five-year net survival for all malignant STS was 65.0%; and was lowest for patients with vascular tumours at 39%. Patients from most deprived cohorts had 23% greater chance of dying within 5 years than patients in least deprived areas. This population-based study has allowed us for the first time to define the incidence and survival rates of prevalent STS subtypes in England such as GIST, liposarcoma and leiomyosarcoma, as well as rare entities and groups with inferior outcome. This data is invaluable for service provision, benchmarking and addressing inequality.

Type: Article
Title: Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ijc.34409
Publisher version: https://doi.org/10.1002/ijc.34409
Language: English
Additional information: © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Keywords: GIST, incidence, sarcoma, survival
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery.ucl.ac.uk/id/eprint/10160877
Downloads since deposit
31Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item